PanaMab is a biotech company, focuses on new target identification and discovery & development of first-in-class and/or bestin- class monoclonal antibodies and companion diagnostics for the treatment of cancers and other serious diseases.

Based on an exclusive global licensing agreement with the University of Texas Health Science Center at Houston and the University of Texas Southwestern. In Mar. 2016 Panamab, moved to J Lab sponsored by Johnson & Johnson for the start-up companies in Houston area.